Your session is about to expire
← Back to Search
Sedentary Reduction Intervention for Type 2 Diabetes
Study Summary
This trial will test a 12-week program to help diabetes patients reduce sedentary behavior and move more. The effects on physical activity, cardiometabolic markers and patient-centered outcomes will also be studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with type 2 diabetes.I sit for 8 hours or more each day.Your HbA1C level is less than 13, as reported by yourself.You have a smartphone.I can stand and walk on my own.I do not have heart, kidney, or other conditions that limit my daily activities.I am 18 years old or older.You have a smartphone.Your blood sugar level is higher than 300.You are currently involved in other exercise or research programs.You are currently using a device to track your physical activity.I use insulin.
- Group 1: Intervention Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers currently seeking participants for this study?
"Per information on clinicaltrials.gov, this particular medical trial is not currently seeking applicants. The initial posting date was 25th of January 2023 and the most recent update to its status occured 10 days after that. This notwithstanding, there are still 1546 active trials looking for participants at present time."
Could you elucidate the main purposes of this medical experiment?
"This trial, which will be tracked for 12 weeks, aims to measure how well participants adhere to the Fitbit device. Secondary objectives include gauging any changes in insulin levels measured with a dried blood spot card after fasting overnight (8+ hours) and analysing cholesterol and HbA1c via the same method."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger